189 related articles for article (PubMed ID: 7953204)
1. A method to measure quality of diabetes treatment: results from an outpatient clinic.
Sandø SH; Hagen C; Beck-Nielsen H
Int J Qual Health Care; 1994 Mar; 6(1):47-54. PubMed ID: 7953204
[TBL] [Abstract][Full Text] [Related]
2. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital.
Otieno FC; Ng'ang'a L; Kariuki M
East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691
[TBL] [Abstract][Full Text] [Related]
3. Serum vaspin levels in type 2 diabetic women in relation to microvascular complications.
Gulcelik NE; Karakaya J; Gedik A; Usman A; Gurlek A
Eur J Endocrinol; 2009 Jan; 160(1):65-70. PubMed ID: 18952766
[TBL] [Abstract][Full Text] [Related]
4. Diabetes guidelines: easier to preach than to practise?
Bryant W; Greenfield JR; Chisholm DJ; Campbell LV
Med J Aust; 2006 Sep; 185(6):305-9. PubMed ID: 16999670
[TBL] [Abstract][Full Text] [Related]
5. Clinical Features and Microvascular Complications Risk Factors of Early-onset Type 2 Diabetes Mellitus.
Huang JX; Liao YF; Li YM
Curr Med Sci; 2019 Oct; 39(5):754-758. PubMed ID: 31612393
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic control and microvascular complications in a large cohort of Italian Type 1 diabetic out-patients.
Lepore G; Bruttomesso D; Nosari I; Tiengo A; Trevisan R
Diabetes Nutr Metab; 2002 Aug; 15(4):232-9. PubMed ID: 12416660
[TBL] [Abstract][Full Text] [Related]
7. Good glycemic control remains crucial in prevention of late diabetic complications--the Linköping Diabetes Complications Study.
Nordwall M; Arnqvist HJ; Bojestig M; Ludvigsson J
Pediatr Diabetes; 2009 May; 10(3):168-76. PubMed ID: 19175900
[TBL] [Abstract][Full Text] [Related]
8. Meeting American Diabetes Association guidelines in endocrinologist practice.
Miller CD; Phillips LS; Tate MK; Porwoll JM; Rossman SD; Cronmiller N; Gebhart SS
Diabetes Care; 2000 Apr; 23(4):444-8. PubMed ID: 10857932
[TBL] [Abstract][Full Text] [Related]
9. Serum and erythrocyte magnesium levels in type I and type II diabetics.
Vanroelen WF; Van Gaal LF; Van Rooy PE; De Leeuw IH
Acta Diabetol Lat; 1985; 22(3):185-90. PubMed ID: 3907234
[TBL] [Abstract][Full Text] [Related]
10. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2.
Babic N; Valjevac A; Zaciragic A; Avdagic N; Zukic S; Hasic S
Med Arch; 2019 Jun; 73(3):163-168. PubMed ID: 31404127
[TBL] [Abstract][Full Text] [Related]
11. Methodology and early findings of the Diabetes Management Project: a cohort study investigating the barriers to optimal diabetes care in diabetic patients with and without diabetic retinopathy.
Lamoureux EL; Fenwick E; Xie J; Mcauley A; Nicolaou T; Larizza M; Rees G; Qureshi S; Wong TY; Benarous R; Dirani M
Clin Exp Ophthalmol; 2012; 40(1):73-82. PubMed ID: 21902788
[TBL] [Abstract][Full Text] [Related]
12. Process measures and outcome research as tools for future improvement of diabetes treatment quality.
Jensen T; Musaeus L; Molsing B; Lyholm B; Mandrup-Poulsen T
Diabetes Res Clin Pract; 2002 Jun; 56(3):207-11. PubMed ID: 11947968
[TBL] [Abstract][Full Text] [Related]
13. The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with Type 2 diabetes mellitus.
Ak G; Buyukberber S; Sevinc A; Turk HM; Ates M; Sari R; Savli H; Cigli A
J Diabetes Complications; 2001; 15(3):150-7. PubMed ID: 11358684
[TBL] [Abstract][Full Text] [Related]
14. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
Abraira C; Colwell JA; Nuttall FQ; Sawin CT; Nagel NJ; Comstock JP; Emanuele NV; Levin SR; Henderson W; Lee HS
Diabetes Care; 1995 Aug; 18(8):1113-23. PubMed ID: 7587846
[TBL] [Abstract][Full Text] [Related]
15. Serum concentrations of laminin-P1 in diabetes mellitus: usefulness as an index of diabetic microangiopathy.
Simó R; Masmiquel L; García-Pascual L; Burgos R; Mateo C; Segura RM; Mesa J
Diabetes Res Clin Pract; 1996 Apr; 32(1-2):45-53. PubMed ID: 8803481
[TBL] [Abstract][Full Text] [Related]
16. Diabetic patients in Saudi Arabia: The evaluation of glycemic control measures based on emergency department utilization and the percentages of adherence to the recommended follow-ups for microvascular complications.
Alshareef SM; Aldayel AY; AlKhathlan MA; Alduaij KO; Alshareef FG; Al-Harthi ME; Aldayel AA; Shadid AM; Dahmash AB
Saudi Med J; 2019 Mar; 40(3):271-276. PubMed ID: 30834423
[TBL] [Abstract][Full Text] [Related]
17. Serum ferritin levels in poorly- and well-controlled diabetes mellitus.
Canturk Z; Cetinarslan B; Tarkun I; Canturk NZ
Endocr Res; 2003 Aug; 29(3):299-306. PubMed ID: 14535631
[TBL] [Abstract][Full Text] [Related]
18. Glycemic control, dyslipidemia and endothelial dysfunction in coexisted diabetes, hypertension and nephropathy.
Shahid SM; Nawab SN; Shaikh R; Mahboob T
Pak J Pharm Sci; 2012 Jan; 25(1):123-9. PubMed ID: 22186319
[TBL] [Abstract][Full Text] [Related]
19. Association of serum high-sensitivity C-reactive protein with metabolic control and diabetic chronic vascular complications in patients with type 2 diabetes.
Chuengsamarn S; Rattanamongkolgul S; Sittithumcharee G; Jirawatnotai S
Diabetes Metab Syndr; 2017; 11(2):103-108. PubMed ID: 27697536
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and risk factors for diabetic retinopathy in 17 152 patients from the island of Funen, Denmark.
Larsen MB; Henriksen JE; Grauslund J; Peto T
Acta Ophthalmol; 2017 Dec; 95(8):778-786. PubMed ID: 28444837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
